Hartman, M. H. T., Eppinga, R. N., Vlaar, P. J. J., Lexis, C. P. H., Lipsic, E., Haeck, J. D. E., . . . van der Harst, P. (2016). The contemporary value of peak creatine kinase‐MB after ST‐segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality. Clin Cardiol.
Stile di citazione ChicagoHartman, Minke H. T., Ruben N. Eppinga, Pieter J. J. Vlaar, Chris P. H. Lexis, Erik Lipsic, Joost D. E. Haeck, Dirk J. van Veldhuisen, Iwan C. C. van der Horst, e Pim van der Harst. "The Contemporary Value of Peak Creatine Kinase‐MB After ST‐segment Elevation Myocardial Infarction Above Other Clinical and Angiographic Characteristics in Predicting Infarct Size, Left Ventricular Ejection Fraction, and Mortality." Clin Cardiol 2016.
Citazione MLAHartman, Minke H. T., et al. "The Contemporary Value of Peak Creatine Kinase‐MB After ST‐segment Elevation Myocardial Infarction Above Other Clinical and Angiographic Characteristics in Predicting Infarct Size, Left Ventricular Ejection Fraction, and Mortality." Clin Cardiol 2016.